Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Venue: Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor
Date: 24-25 November (Pre-Conference Workshops) & 26-27 November 2025 (ICDDTM'25 Conference)
Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
    • The Venue
      • Nearby Hotels
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
      • Travel Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Prof. Dr Lim Lee Ling

Prof. Dr Lim Lee Ling
Diabetes Care
Universiti Malaya, Malaysia

———————————————————————-

Prof. Dr Lim Lee Ling is Professor of Medicine, UM and Head of the Diabetes Care Unit, Universiti Malaya Medical Centre. As a clinician-scientist, her major areas of interest include cardiometabolic medicine and intergenerational diabetes with translational and implementation science components. 

Dr. Lim sits on the Working Groups of The Lancet Commission on Diabetes and the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative, who provide authoritative resources in tackling the global diabetes epidemic. She recognizes that every person with diabetes and non-communicable disease (NCD) is unique and warrants personalized care. To revolutionize health care, Dr. Lim aims to advance the implementation of Precision Medicine in Diabetes and NCD, taking into account differences in clinical presentation, genes, and lifestyles in Malaysian populations. These have led to several collaborations with the USA, UK, and other Asian countries. She has published in numerous high-impact journals including The Lancet, Nature, Diabetes Care, and Science Bulletin. 

Dr. Lim has received several awards including the World’s Top 2% Scientists by Stanford University for 3 consecutive years (2022-2024), the EFSD Albert Renold Fellowship, the USA Endocrine Society Outstanding Abstract Award, and a scholarship funded by the USA NIH National Institute of General Medical Sciences for training in statistical genetics at the University of Washington, USA.

She is an Editorial Board Member of several Tier 1 Web of Science-indexed journals (BMC Medicine, Diabetes/Metabolism Research & Reviews, and Diabetes & Metabolism). Dr. Lim is an article reviewer for 29 leading academic journals including the European Heart Journal, Annals of Internal Medicine, Diabetes Care, PLoS Medicine, and European Journal of Preventive Cardiology.

Note: Click [x] on top-right or anywhere on this pop-up to exit

 

Category:

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Right click and Save As ICDDTM'25 Poster

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Yantai Affiliated Hospital of Binzhou Medical University, China)
(Universitas Andalas, Padang, Indonesia)
(Dhaka University, Bangladesh)
© 2025 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Organised by Malaysian Association for Cancer Research